Suppr超能文献

Nexgen Legacy后稳定型固定平台膝关节置换术的中长期结果

Medium- to Long-Term Results of the Nexgen Legacy Posterior Stabilized Fixed-Bearing Knee Replacement.

作者信息

Arikupurathu Oommen Mathew, Johnston Linda, MacInnes Alasdair, Nicol Graeme, Nassif Manhal

机构信息

University Department of Orthopaedic and Trauma Surgery, Tayside Orthopaedic and Rehabilitation Centre (TORT), Ninewells Hospital and Medical School, University of Dundee, Dundee, United Kingdom.

Directorate of Orthopaedic and Trauma Surgery, Ninewells Hospital and Medical School, Dundee, United Kingdom.

出版信息

J Knee Surg. 2019 Jun;32(6):554-559. doi: 10.1055/s-0038-1660477. Epub 2018 Jun 20.

Abstract

The NexGen legacy posterior stabilized (LPS) prosthesis was introduced in 1997 after many design changes to its predecessor, the Insall-Burstein II prosthesis. However, there have been no reported long-term studies on the performance of this implant. Prospectively, collected data from a local database comprising primary total knee replacements (TKRs) with LPS between 1997 and 2002 was analyzed. All implants were fixed with cement. Patients were followed up at 1, 3, 5, 7, and 10 years, with patient satisfaction, range of movement, and Knee Society score (KSS) assessed. A total of 621 primary TKRs were analyzed with an average follow-up of 11.25 years (9.15-14.55). The mean age was 69.53 years. The mean KSS was 88.97 and mean flexion increased from 88.3 to 103.5 degrees at 10 years. Kaplan-Meier's analysis revealed a survivorship of 96.5% with revision for any reason as the end point and 98.9% if aseptic loosening was the reason for revision at 14 years. This study revealed excellent mid- to long-term results with the NexGen LPS prosthesis.

摘要

NexGen传统后稳定型(LPS)假体于1997年推出,此前其前身Insall-Burstein II假体经历了多次设计变更。然而,尚无关于该植入物性能的长期研究报告。前瞻性地分析了从本地数据库收集的数据,该数据库包含1997年至2002年间使用LPS进行的初次全膝关节置换术(TKR)。所有植入物均用骨水泥固定。对患者进行1年、3年、5年、7年和10年的随访,评估患者满意度、活动范围和膝关节协会评分(KSS)。共分析了621例初次TKR,平均随访11.25年(9.15 - 14.55年)。平均年龄为69.53岁。平均KSS为88.97,10年时平均屈曲度从88.3度增加到103.5度。Kaplan-Meier分析显示,以任何原因翻修为终点时,14年的生存率为96.5%;以无菌性松动为翻修原因时,生存率为98.9%。这项研究表明NexGen LPS假体具有出色的中长期效果。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验